Results

Total Results: 439 records

Showing results for "diabetes treatment".
Users also searched for: diabetes guidelines

21. Secyfgzqgdoqdd8J4Ccvuy (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/SEcYfGZqGdoqdd8j4CCVuy
    May 01, 2008 - versus no therapy for mild gestational diabetes. … Diabetes, Gestational/dh, dt, pc, th [Diet Therapy, Drug Therapy, Prevention & Control, Therapy] 2. … New therapies for the pregnant patient with diabetes. Diabetes Technol Ther. 2001;3:635-40. … versus no therapy for mild gestational diabetes. … Treatments for gestational diabetes and impaired glucose tolerance in pregnancy.

22. Pdf (pdf file)
    www.uspreventiveservicestaskforce.org/Home/GetFile/1/588/gdart/pdf
    May 01, 2008 - versus no therapy for mild gestational diabetes. … Diabetes, Gestational/dh, dt, pc, th [Diet Therapy, Drug Therapy, Prevention & Control, Therapy] 2. … New therapies for the pregnant patient with diabetes. Diabetes Technol Ther. 2001;3:635-40. … versus no therapy for mild gestational diabetes. … Treatments for gestational diabetes and impaired glucose tolerance in pregnancy.

23. Screening for Type 2 Diabetes Mellitus in Adults: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/MtCxSYE8eYd2EzUGV8cMzH
    Screening for Type 2 Diabetes Mellitus in Adults: U.S. … For example, if CHD risk without diabetes was 17% and risk with diabetes was >20%, screening for diabetes … would be helpful because diabetes status would determine lipid treatment. … In contrast, if risk without diabetes was 10% and risk with diabetes was 15%, screening would not affect … the decision to use lipid-lowering treatment.

24. Evidence Summary: Prediabetes and Type 2 Diabetes: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/screening-for-prediabetes-and-type-2-diabetes
    August 24, 2021 - each included study, 1 investigator extracted pertinent information about the populations, tests or treatments … Saxagliptin as initial therapy in treatment-naive Indian adults with type 2 diabetes mellitus inadequately … Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes … Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE … Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes

25. W-9Tarc9Nkw6Pe4Sfddmkz (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/W-9TArc9nkw6Pe4sfddMKZ
    July 01, 2013 - Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. … Evaluating the therapeutic approach in pregnancies complicated by borderline glucose intolerance: a … or therapy or therapies).mp. 43. manage$.mp. 44. monitor$.mp. 45. exp sulfonylurea compounds/ 46. … mp. 57. glibenclamid$.mp. 58. acarbos$.mp. 59. exp Diet Therapy/ 60. … Favors treatment Favors no treatment GDM � gestational diabetes mellitus; IV � inverse variance; RCT

26. 4Z Bygyyfkv5Uru6Fjx8Pb (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/4z_ByGyYfKV5uRU6fjx8pB
    March 01, 2014 - Treatment Initial treatment includes moderate physical activity, dietary changes, support from diabetes … Additional studies are needed to evaluate the effect of dif- ferent treatments for GDM on longer-term … Therapeutic management, delivery, and postpartum risk assess- ment and screening in gestational diabetes … A multicenter, random- ized trial of treatment for mild gestational diabetes. … Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.

27. Final Research Plan: Prediabetes and Type 2 Diabetes: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/screening-for-prediabetes-and-type-2-diabetes
    November 15, 2018 - with no intervention, usual care, or interventions with different treatment targets?     … , usual care, or interventions with different treatment targets?     … threshold) KQs 4, 5: No intervention, placebo, usual care (can include minimal intervention), different treatment … , harms from false-positive results, burden, inconvenience, depression, and unnecessary testing and treatment … KQ 6: Serious side effects from treatment, including mortality, myocardial infarction, stroke, cancer

28. Archived: Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-for-abnormal-blood-glucose-and-type-2-diabetes-october-2015
    October 26, 2015 - The harms of drug therapy for the prevention of diabetes are small to moderate, depending on the drug … More U.S. data are also needed on the benefits and harms of lifestyle interventions and medical treatments … = 0.01). 25 Lipid-lowering therapy seemed to be similarly effective in RR reduction regardless of diabetes … Effects of combination lipid therapy in type 2 diabetes mellitus. … Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins

29. Archived: Final Research Plan: Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan16/screening-for-abnormal-blood-glucose-and-type-2-diabetes-october-2015
    August 15, 2013 - Links in the chain of indirect evidence include the effectiveness of screening and treatments in reducing … the incidence of future health outcomes and the harms associated with screening and treatments. … to identify individuals who have the disease; it is also necessary to show that there are effective treatments … quality of life KQ 2: Labeling, anxiety, false-positive results KQ 4: Serious side effects from treatments … clarified that the decision to only include large studies is intended for the key question on harms of treatment

30. Archived: Published Comment and Response: Do Lipid-Lowering Agents Provide a Greater Reduction in Cardiovascular Events among Patients with Diabetes?: Diabetes Mellitus (Type 2) in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/published-comment-and-response-do-lipid-lowering-agents-provide-a-greater-reduction-in-cardiovascular-events-among-patients-with-diabetes/diabetes-mellitus-type-2-in-adults-screening-2008
    November 15, 2008 - : Do Lipid-Lowering Agents Provide a Greater Reduction in Cardiovascular Events among Patients with Diabetes … Diabetes Mellitus (Type 2) in Adults: Screening November 15, 2008 Recommendations made by the USPSTF … based, at least in part, on an analysis of the secondary prevention trials, which showed that lipid treatment … Therefore, reductions in absolute percentage (and not relative percentage) of CHD events with lipid treatment … Screening for type 2 diabetes mellitus in adults: U.S.

31. Screening for Gestational Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/TYPA75a_t7HaJeDhWqCJ9n
    August 13, 2019 - For treatment, the population was women with gestational diabetes or hyperglycemia. … Evaluating the therapeutic approach in pregnancies complicated by borderline glucose intolerance: a randomized … Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. … A multicenter, randomized trial of treatment for mild gestational diabetes. … Effect of treatment of mild gestational diabetes on long-term maternal outcomes.

32. Screening for Gestational Diabetes Mellitus: Clinical Summary of USPSTF Recommendation (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/zuBMgkDP5VuWPPQCpfcSey
    Screening for Gestational Diabetes Mellitus: Clinical Summary of USPSTF Recommendation SCREENING … FOR GESTATIONAL DIABETES MELLITUS CLINICAL SUMMARY OF U.S. … , and belonging to an ethnic group with increased risk for type 2 diabetes mellitus (Hispanic, Native … Screening Tests There are 2 strategies used to screen for gestational diabetes in the United States … Treatment Initial treatment includes moderate physical activity, dietary changes, support from diabetes

33. Archived: Gestational Diabetes Mellitus: Screening, 2003 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/gestational-diabetes-mellitus-screening-2003
    February 01, 2003 - The differences in the timing of screening and the treatments in the study groups make it difficult to … Data on the effects of diet therapy alone for treating GDM are limited. … related to screening for GDM, including the costs of screening and diagnostic tests, costs of various treatments … Gestational diabetes mellitus (GDM) comparative evaluation of two treatment regimens, diet versus insulin … Emotional adjustment to diagnosis and intensified treatment of gestational diabetes.

34. Tjdzc7Rzm3Wzcdhfc4Sjhq (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/TjDzC7rzm3WzCDHFC4sJhQ
    June 01, 2015 - More evidence is needed to determine the effectiveness of treatments for screen-detected diabetes. … Treatment of IFG or IGT was associated with delayed progression to diabetes. … Treatment of IFG or IGT was associated with delayed progression to diabetes. … Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE … Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes

35. Effectiveness of Primary Care–Relevant Treatments for Obesity in Adults: A Systematic Evidence Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/hbSopN6uA9u-4EQuKtRGDP
    October 01, 2011 - Weight-loss treatment re- duced diabetes incidence in participants with prediabetes. … Role of orlistat in the treatment of obese patients with type 2 diabetes. … Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes … Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes … Behavioral and pharmacologic therapies for obesity. Nat Rev Endocrinol. 2010;6:578-88.

36. Archived: Evidence Summary: Asymptomatic Bacteriuria in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary11/asymptomatic-bacteriuria-in-adults-screening-2008
    July 15, 2008 - with diabetes met inclusion criteria for this update. … After the initial round of therapy, significantly ( P < 0.001) more women in the placebo group continued … These findings suggest that screening and treatment for asymptomatic bacteriuria in women with diabetes … Manitoba Diabetes Urinary Tract Infection Study Group. … group Treating asymptomatic bacteriuria in nonpregnant women with diabetes increased antibiotic use

37. Screening for Asymptomatic Bacteriuria in Adults: Evidence for the U.S. Preventive Services Task Force Reaffirmation Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/RoC9VuSorM_LR7sTvLeFF2
    July 01, 2008 - in nonpregnant women with diabetes met inclusion criteria for this update. … group Treating asymptomatic bacteriuria in nonpregnant women with diabetes increased antibiotic use … After the initial round of therapy, significantly (P � 0.001) more women in the placebo group continued … These findings suggest that screening and treatment for asymptomatic bacteriuria in women with diabetes … Manitoba Diabetes Uri- nary Tract Infection Study Group.

38. Archived: Final Evidence Review: Asymptomatic Bacteriuria in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review11/asymptomatic-bacteriuria-in-adults-screening-2008
    July 15, 2008 - with diabetes met inclusion criteria for this update. … Eligible patients were nonpregnant women older than 16 years of age with diabetes, normal renal function … After the initial round of therapy, significantly ( P  < 0.001) more women in the placebo group continued … These findings suggest that screening and treatment for asymptomatic bacteriuria in women with diabetes … Manitoba Diabetes Urinary Tract Infection Study Group.

39. Archived: Evidence Summary: Aspirin Use to Prevent Cardiovascular Events: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cardiovascular/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    April 11, 2016 - Diabetes Available evidence does not clearly support the heterogeneity of aspirin's treatment effect … The 11 primary prevention studies are heterogeneous in terms of aspirin dose; duration of therapy; baseline … conclude that the cardiovascular-related benefits (that is, nonfatal MI) occur during the first 5 years of therapy … AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic … Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of

40. Final Research Plan: Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/obesity-in-adults-interventions
    March 31, 2016 - What health effects (i.e., mortality and incidence of cardiovascular disease, type 2 diabetes mellitus … of cardiovascular disease Management of diabetes * Treatment of cancer Condition definition … loss/maintenance is part of disease management (e.g., osteoarthritis, known cardiovascular disease, diabetes … of type 2 diabetes (e.g., metformin, pramlintide, empagliflozin, albiglutide, dulaglutide, alogliptin … , exenatide) Complementary and alternative treatments (e.g., acupuncture, mindfulness) Dietary supplements